Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hackshaw

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Nature Cancer|January 10, 2024
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinomaXiaoxi Pan, Khalid AbdulJabbar, Jose Coelho-Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical CarcinomaAndrea G Rockall, Tara D Barwick, William Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)Siow Ming Lee, Mary Falzon, Fiona Blackhall, et al.
Thorax|July 21, 2022
Telephone risk-based eligibility assessment for low-dose CT lung cancer screeningJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Chest|June 30, 2026
Symptom prevalence and impact on lung cancer risk in the SUMMIT studyMonica L Mullin, Andrew W Creamer, Amyn Bhamani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2022
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programmeJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lancet (London, England)|December 19, 2015
Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trialsJane Wardle, Christian von Wagner, Ines Kralj-Hans, et al.
JAMA|December 4, 2019
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical TrialPeter J Hoskin, Kirsten Hopkins, Vivek Misra, et al.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
British Journal of Cancer|January 8, 2016
Impact of general practice endorsement on the social gradient in uptake in bowel cancer screeningRosalind Raine, Stephen W Duffy, Jane Wardle, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Nature Cancer|January 10, 2024
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinomaXiaoxi Pan, Khalid AbdulJabbar, Jose Coelho-Lima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical CarcinomaAndrea G Rockall, Tara D Barwick, William Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)Siow Ming Lee, Mary Falzon, Fiona Blackhall, et al.
Thorax|July 21, 2022
Telephone risk-based eligibility assessment for low-dose CT lung cancer screeningJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Chest|June 30, 2026
Symptom prevalence and impact on lung cancer risk in the SUMMIT studyMonica L Mullin, Andrew W Creamer, Amyn Bhamani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2022
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programmeJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lancet (London, England)|December 19, 2015
Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trialsJane Wardle, Christian von Wagner, Ines Kralj-Hans, et al.
JAMA|December 4, 2019
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical TrialPeter J Hoskin, Kirsten Hopkins, Vivek Misra, et al.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
British Journal of Cancer|January 8, 2016
Impact of general practice endorsement on the social gradient in uptake in bowel cancer screeningRosalind Raine, Stephen W Duffy, Jane Wardle, et al.
Pageof 17